[
  {
    "ticker": "ACAD",
    "drug_name": "Pimavanserin",
    "indication": "Major Depressive Disorder",
    "pdufa_date": "2026-04-03",
    "submission_type": "sNDA",
    "confidence": "confirmed",
    "source": "company_guidance"
  },
  {
    "ticker": "AXSM",
    "drug_name": "AXS-05",
    "indication": "Alzheimer's Disease Agitation",
    "pdufa_date": "2026-05-22",
    "submission_type": "NDA",
    "confidence": "confirmed",
    "source": "company_guidance"
  },
  {
    "ticker": "CYTK",
    "drug_name": "Aficamten",
    "indication": "Hypertrophic Cardiomyopathy",
    "pdufa_date": "2026-03-28",
    "submission_type": "NDA",
    "confidence": "confirmed",
    "source": "company_guidance"
  },
  {
    "ticker": "INSM",
    "drug_name": "Brensocatib",
    "indication": "Bronchiectasis",
    "pdufa_date": "2026-03-14",
    "submission_type": "NDA",
    "confidence": "confirmed",
    "source": "company_guidance"
  },
  {
    "ticker": "KRYS",
    "drug_name": "KarXT",
    "indication": "Schizophrenia",
    "pdufa_date": "2026-02-28",
    "submission_type": "NDA",
    "confidence": "confirmed",
    "source": "company_guidance"
  },
  {
    "ticker": "MRNA",
    "drug_name": "mRNA-1345",
    "indication": "RSV Vaccine",
    "pdufa_date": "2026-05-12",
    "submission_type": "BLA",
    "confidence": "estimated",
    "source": "analyst_estimate"
  },
  {
    "ticker": "NBIX",
    "drug_name": "Elahere",
    "indication": "Ovarian Cancer 2L",
    "pdufa_date": "2026-04-15",
    "submission_type": "sBLA",
    "confidence": "confirmed",
    "source": "company_guidance"
  },
  {
    "ticker": "REGN",
    "drug_name": "Dupixent",
    "indication": "COPD",
    "pdufa_date": "2026-06-27",
    "submission_type": "sBLA",
    "confidence": "confirmed",
    "source": "company_guidance"
  },
  {
    "ticker": "RVMD",
    "drug_name": "RVT-3101",
    "indication": "Ulcerative Colitis",
    "pdufa_date": "2026-07-15",
    "submission_type": "BLA",
    "confidence": "estimated",
    "source": "analyst_estimate"
  },
  {
    "ticker": "SRPT",
    "drug_name": "Elevidys",
    "indication": "DMD (Full Approval)",
    "pdufa_date": "2026-06-21",
    "submission_type": "sBLA",
    "confidence": "confirmed",
    "source": "company_guidance"
  },
  {
    "ticker": "VRTX",
    "drug_name": "VX-548",
    "indication": "Acute Pain",
    "pdufa_date": "2026-03-30",
    "submission_type": "NDA",
    "confidence": "confirmed",
    "source": "company_guidance"
  }
]
